System Transmission

Top Signal

100#1 JOB

Activity

2163Ripe

+917 today

System

Live1m

Terminal Asset View

stockNASDAQ

CLRB

$3.20-0.93%

Cellectar Biosciences Inc

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

41Neutral

Live Analysis Active

Company Mission

Cellectar Biosciences creates cancer treatments that use special molecules to carry radiation directly to tumor cells. Doctors use these experimental drugs in clinical trials to treat patients with various cancers. The company makes money by advancing these treatments through research stages and hopes to eventually sell approved drugs to hospitals and healthcare providers.

CLR

Industry Context

The biotech industry focuses on developing new medical treatments using biological science. Companies in this space often work on targeted therapies that attack specific disease cells while sparing healthy ones. This approach is gaining attention as it can reduce side effects compared to traditional treatments.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

67Matrix

Market Momentum

52.0— Holding Steady

Trend Strength

75— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

1.0x— Normal Volume

Today's Change

-0.93%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing CLRB across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 07:30 PM UTC

As-of 03-14-2026 19:14 UTC

Develops cancer drugs that target tumor cells while sparing healthy tissue, earning revenue from research grants and future drug sales.

Weekly chart shows price coiling in a tighter range near recent levels, suggesting a potential breakout move is building up energy.

Biotech sector sees increased interest in targeted therapies, which could benefit companies developing precision cancer treatments like this one.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...